trending Market Intelligence /marketintelligence/en/news-insights/trending/8W3cPusXRM6Dbp9jAuJOpw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Abbott extends tender offer deadline for Alere preferred stock

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Abbott extends tender offer deadline for Alere preferred stock

Abbott Laboratories extended its cash tender offer to acquire all outstanding series B convertible perpetual preferred stock of Alere Inc.

Abbott launched the offer to acquire Alere's preferred stock at $402 apiece, plus accrued but unpaid dividends, on July 17. The tender offer, originally set to expire Aug. 11, has been extended to Aug. 31. More than 90% of the issued and outstanding shares of Preferred Stock had been tendered as of Aug. 11.

The acquisition valued at $5.3 billion is not conditional on the completion of the offer.

Barclays Capital Inc. is the dealer-manager for the offer, with D.F. King & Co. Inc. as information agent.